• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CHEMISTRY HEMOGLOBIN A1C_3 REAGENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CHEMISTRY HEMOGLOBIN A1C_3 REAGENTS Back to Search Results
Model Number ADVIA CHEMISTRY HEMOGLOBIN A1C_3 REAGENTS
Device Problem Device Ingredient or Reagent Problem (2910)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/05/2015
Event Type  malfunction  
Manufacturer Narrative
Siemens healthcare diagnostics has confirmed the hemoglobin a1c_3/ a1c_3m reagent kit lots 230 ((b)(4)) and 231((b)(4)) used on the advia 1200, 1650, 1800, 2400, and xpt chemistry systems may demonstrate an increased occurrence of high %hba1c bias.Siemens internal investigation demonstrates reagent lots 230 and 231 may exhibit a positive bias averaging 0.6% hba1c units, ranging from -0.1% to 1.1% hba1c units.The bias was observed when comparing %hba1c means to ngsp pooled patient target-value assigned samples ranging from approximately 5.5% to 8.0% hba1c.The maximum bias was observed at higher %hba1c concentrations.Qc samples may exhibit a similar bias.An urgent medical device correction (umdc) chc-15-19 is being sent to us customers and a urgent field safety notice (ufsn) chc-15-19 is being sent to ous customers in september of 2015.The umdc and ufsn state that customers are to discontinue use and discard reagent kit lots 230 and 231.
 
Event Description
The customer has indicated that they are noticing a positive bias on quality control samples and patient samples for the hemoglobin a1c_3 assay on the advia chemistry 1800 instrument when using reagent lot 230.The customer ran a correlation study using patient samples with reagent lots 210 and 230 and noticed a bias ranging from 1.96% to 9.3% with reagent lot 230.There were no reports of patient intervention or adverse health consequences due to the positive bias on quality control samples or patient samples.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CHEMISTRY HEMOGLOBIN A1C_3 REAGENTS
Type of Device
ADVIA CHEMISTRY HEMOGLOBIN A1C_3 REAGENTS
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS (REF#2517506)
500 gbc drive
p.o. box 6101
newark DE 19714 6101
Manufacturer Contact
aarti aziz
511 benedict avenue
tarrytown, NY 10591
9145242683
MDR Report Key5299601
MDR Text Key33569669
Report Number2432235-2015-00586
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K110934
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Remedial Action Recall
Type of Report Initial
Report Date 09/22/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model NumberADVIA CHEMISTRY HEMOGLOBIN A1C_3 REAGENTS
Device Catalogue Number10379673, 10485591
Device Lot Number230
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/18/2015
Was Device Evaluated by Manufacturer? No
Type of Device Usage Initial
Removal/Correction Number2517506-09/30/2015-007-R
Patient Sequence Number1
-
-